CRISPR Therapeutics
CRSP
CRSP
135 hedge funds and large institutions have $855M invested in CRISPR Therapeutics in 2018 Q1 according to their latest regulatory filings, with 65 funds opening new positions, 34 increasing their positions, 26 reducing their positions, and 12 closing their positions.
Holders
135
Holders Change
+52
Holders Change %
+62.65%
% of All Funds
3.1%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.11%
New
65
Increased
34
Reduced
26
Closed
12
Calls
$8.41M
Puts
$30.4M
Net Calls
-$22M
Net Calls Change
-$23.7M